Tags: diabetes | type 2 | Glyxambi | glucose | control

Help for Type 2 Diabetes

Monday, 02 Feb 2015 12:16 PM

The U.S. Food and Drug Administration approved a drug developed by Eli Lilly and Co and privately held Boehringer Ingelheim Pharmaceuticals Inc to improve blood sugar control in type-2 diabetes patients, the companies said.
The drug, Glyxambi, combines empagliflozin and linagliptin, commonly prescribed diabetes medications which are manufactured by Lilly and Boehringer.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
FDA-Approved-Drugs
The U.S. Food and Drug Administration approved a drug developed by Eli Lilly and Co and privately held Boehringer Ingelheim Pharmaceuticals Inc to improve blood sugar control in type-2 diabetes patients, the companies said.The drug, Glyxambi, combines empagliflozin and...
diabetes, type 2, Glyxambi, glucose, control
52
2015-16-02
Monday, 02 Feb 2015 12:16 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved